PDAP1, or PDGF-associated protein 1, plays a pivotal role in cellular signaling pathways associated with growth factor responsiveness, particularly the PDGF (Platelet-Derived Growth Factor) signaling pathway. This involvement is critical for the regulation of cellular processes such as proliferation, migration, and survival. PDAP1 functions as an adaptor protein, which means it facilitates the assembly of signaling complexes that activate various downstream pathways. Its activity is crucial in contexts where cellular responses to external growth signals determine functional outcomes, such as during tissue repair and development. Through its interaction with components of the cytoskeleton, PDAP1 also influences cellular architecture, contributing to changes in cell shape and motility in response to growth factor stimulation. The role of PDAP1 in these processes underscores its significance in maintaining cellular and tissue homeostasis, as well as its potential involvement in pathological conditions where cell signaling is aberrantly regulated.
The activation of PDAP1 is primarily governed by its association with PDGF receptors and subsequent participation in the receptor's signaling cascade. Upon PDGF binding to its receptors, PDAP1 is recruited to the receptor complex where it can interact with other signaling molecules. This recruitment is typically mediated through specific interaction domains within PDAP1 that recognize phosphorylated tyrosine residues on the activated receptor or other adaptor proteins in the complex. Once part of this assembly, PDAP1 can facilitate the propagation of signals by serving as a scaffold that organizes other signaling proteins, thereby enhancing their ability to effect changes in cellular behavior. The activation of PDAP1 can also be modulated by post-translational modifications, such as phosphorylation. These modifications can alter the conformation or the interaction capabilities of PDAP1, impacting its ability to participate in signaling complexes. Moreover, the localization of PDAP1 within the cell can affect its activity; for instance, translocation to membrane regions or particular organelles can position PDAP1 where it can effectively interact with its targets and regulators. Understanding the dynamics of PDAP1 activation, including the biochemical modifications and spatial distribution that modulate its function, offers deep insights into how cells respond to growth factors and adjust their behavior in accordance with physiological needs and environmental cues. This knowledge extends our comprehension of cellular communication mechanisms and highlights the intricate regulation of signaling networks that sustain cellular and tissue function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid modulates gene expression via the retinoic acid receptor (RAR). It can alter the transcription of genes, possibly including those encoding PDZ domain-containing proteins, thus modulating PDAP1 indirectly by changing its cellular context. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog that activates PKA, leading to changes in phosphorylation states of various proteins. If PDAP1 is a substrate, this would modify its activity or interactions with other proteins. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
GSK-3 inhibitor that impacts Wnt signaling and possibly β-catenin levels, which are involved in cellular adhesion and signaling pathways that could intersect with PDAP1's role in the cell. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, IBMX increases intracellular cAMP, which in turn can activate PKA and potentially affect proteins associated with PDAP1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
A potent inhibitor of protein phosphatases 1 and 2A, okadaic acid can lead to increased phosphorylation of proteins, which may affect PDAP1 protein interactions or function. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $63.00 $250.00 | 13 | |
A dihydrochalcone that inhibits various transport proteins and can alter cellular signaling and metabolism, potentially affecting PDAP1 by changing intracellular conditions. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP and subsequently activating PKA. This can lead to changes in phosphorylation status of PDZ domain-containing proteins, which might affect PDAP1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A beta-adrenergic agonist that increases cAMP and activates PKA, potentially modifying the interaction landscape of PDAP1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor that can modulate various signaling pathways, potentially altering PDZ domain-containing protein functions and interactions including PDAP1. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $50.00 $70.00 $195.00 | 11 | |
Inhibits Syk kinase and potentially modulates signaling pathways that involve PDZ domain-containing proteins, thereby possibly affecting PDAP1. |